Mergers & Acquisitions

A New York bankruptcy judge has authorized the sale of Seelos Therapeutics' remaining assets for $22 million, effectively concluding the...

The acquisition of 2Seventy Bio by Bristol Myers Squibb in March 2025 for $286 million has effectively rendered the company's...

A significant strategic shift is underway at Synopsys, the semiconductor design specialist, following crucial regulatory developments. The company received formal...

While traditional exchanges continue operating with conventional derivatives, Intercontinental Exchange is aggressively pursuing the next financial revolution. The operator of...

The corporate transformation of Ikena Oncology into ImageneBio has reached a significant administrative milestone with the recent submission of regulatory...

Faro's corporate journey has reached its conclusion as shareholders overwhelmingly endorsed AMETEK's acquisition offer. The industrial conglomerate will pay $44...

The protracted uncertainty surrounding Thyssenkrupp's most significant challenge may finally be approaching a resolution. A new, determined bidder has emerged...

Defense technology specialist Hensoldt is charting new territory with a groundbreaking entry into civilian aerospace markets. The MDAX-listed company's newly...

Salesforce has thrown down the gauntlet in the competitive technology sector, earning enthusiastic responses from investors with its latest strategic...

Blue Owl Capital finds itself at a pivotal juncture as the alternative asset manager pursues aggressive expansion through billion-dollar strategic...